Actualités

Exact Sciences Corp. a annoncé l'extension de son partenariat avec Humana Inc. afin d'améliorer l'accès au dépistage du ...
Cologuard Plus, lancé en mars 2025, a reçu l’approbation de la FDA, la couverture Medicare et l’inclusion dans les directives du Groupe de travail américain sur les services préventifs. Le test est ...
The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...
Humana a relevé ses prévisions de bénéfices annuels après avoir dépassé les attentes trimestrielles mercredi, l'assureur santé américain étant parvenu à contenir ses coûts ...
Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members.
Here are four updates on gastroenterology and endoscopy companies. London-based Lumendi received 510(k) clearance from the FDA for its DiLumen, an endoscopic accessory. Laval, Quebec-based Valeant ...
Fact checked by Nick Blackmer Cologuard is getting an upgrade soon. An updated at-home screening test, called Cologuard Plus, is expected to be available in June 2025. Cologuard Plus is a more ...